ILK and breast cancer: Alternatively, helical or kinase domain mutants may activate a different set of PIP3 targets such as ILK or SGK3, an estrogen-regulated AGC family kinase that is required for survival of the ERα-positive breast cancer cell line MCF7 [141, 142].